Clinical Trials Browser

Phase 2/3 × Recurrence × Capecitabine × Clear all

NCT00561522 2010-07-21

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence